Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
399
|
pubmed:dateCreated |
1996-1-11
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0960-1643
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
563-4
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:7492431-Adult,
pubmed-meshheading:7492431-Aged,
pubmed-meshheading:7492431-Aged, 80 and over,
pubmed-meshheading:7492431-Cerebrovascular Disorders,
pubmed-meshheading:7492431-Humans,
pubmed-meshheading:7492431-Middle Aged,
pubmed-meshheading:7492431-Risk Factors,
pubmed-meshheading:7492431-Warfarin
|
pubmed:year |
1995
|
pubmed:articleTitle |
Warfarin in stroke prevention.
|
pubmed:publicationType |
Letter,
Comment
|